dipyridamole has been researched along with Basilar Artery Insufficiency in 5 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We compared the outcomes of 2,500 patients who suffered from previous cerebrovascular disorders (transient ischemic attacks, reversible ischemic neurologic deficits, or completed strokes) treated with acetylsalicylic acid plus dipyridamole or matched placebo and followed for 2 years." | 5.06 | European Stroke Prevention Study. ESPS Group. ( , 1990) |
| "Indications for surgery included vertebrobasilar insufficiency (22." | 1.30 | Carotid-subclavian bypass for subclavian artery revascularization: long-term follow-up and effect of antiplatelet therapy. ( Dresler, C; Haverich, A; Wahlers, T; Wittwer, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keim, RJ | 1 |
| Wittwer, T | 1 |
| Wahlers, T | 1 |
| Dresler, C | 1 |
| Haverich, A | 1 |
| Sivenius, J | 2 |
| Riekkinen, PJ | 2 |
| Kilpeläinen, H | 1 |
| Laakso, M | 2 |
| Penttilä, I | 1 |
| Smets, P | 1 |
| Lowenthal, A | 1 |
3 trials available for dipyridamole and Basilar Artery Insufficiency
| Article | Year |
|---|---|
Antiplatelet therapy is effective in the prevention of stroke or death in women: subgroup analysis of the European Stroke Prevention Study (ESPS).
Topics: Aspirin; Cause of Death; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; | 1991 |
The European Stroke Prevention Study (ESPS): results by arterial distribution.
Topics: Aspirin; Carotid Arteries; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Drug Therap | 1991 |
European Stroke Prevention Study. ESPS Group.
Topics: Age Factors; Aspirin; Brain Ischemia; Carotid Artery Diseases; Cerebrovascular Disorders; Clinical T | 1990 |
2 other studies available for dipyridamole and Basilar Artery Insufficiency
| Article | Year |
|---|---|
William F. House Lecture. Neurotologic manifestations of microvascular hypoperfusion.
Topics: Brain; Dipyridamole; Female; Hearing Disorders; Humans; Male; Platelet Aggregation Inhibitors; Postu | 1995 |
Carotid-subclavian bypass for subclavian artery revascularization: long-term follow-up and effect of antiplatelet therapy.
Topics: Adult; Aged; Angiography; Anticoagulants; Arm; Arterial Occlusive Diseases; Aspirin; Blood Vessel Pr | 1998 |